stella
beta
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia — Stella
Recruiting
Back to Relapsed Myelodysplastic Syndrome trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
View full record on ClinicalTrials.gov